PH-dependent disruption of Escherichia coli ATCC 25922 and model membranes by the human antimicrobial peptides hepcidin 20 and 25

FEBS Journal

Volumn 280, Issue 12, 2013, Pages 2842-2854

  Maisetta, Giuseppantonio ^a   Vitali, Alberto ^b   Scorciapino, Mariano A ^c   Rinaldi, Andrea C ^c   Petruzzelli, Raffaele ^d   Brancatisano, Franca L ^a   Esin, Semih ^a   Stringaro, Annarita ^e   Colone, Marisa ^e   Luzi, Carla ^f   Bozzi, Argante ^f   Campa, Mario ^a   Batoni, Giovanna ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

^e Dipartimento di Salute Mentale   (Italy)

^f UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

acid activated antimicrobial peptides; human hepcidins; membrane damage; NMR; SEM

Indexed keywords

ANTIINFECTIVE AGENT; BETA GALACTOSIDASE; DEXTRAN; HEPCIDIN 20; HEPCIDIN 25; LIPOSOME; PHOSPHOLIPID; POLYDIACETYLENE; POLYMER; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; CELL AGGREGATION; CELL MEMBRANE PERMEABILITY; COLORIMETRY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME RELEASE; ESCHERICHIA COLI; FLOW CYTOMETRY; INTERNALIZATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR INTERACTION; MOLECULAR SIZE; NONHUMAN; PH; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-GALACTOSIDASE; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DEXTRANS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, ELECTRON, SCANNING; PEPTIDE FRAGMENTS; UNILAMELLAR LIPOSOMES;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84878766367     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12288     Document Type: Article

References (55)

1. Zhang L, &, Falla TJ, (2010) Potential therapeutic application of host defense peptides. Methods Mol Biol 618, 303-327.
2. Hancock RE, &, Sahl HG, (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24, 1551-1557.
3. Hancock RE, (2001) Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 1, 156-164.
4. Lohner K, (2009) New strategies for novel antibiotics: peptides targeting bacterial cell membranes. Gen Physiol Biophys 28, 105-116.
5. Hallock KJ, Lee DK, Omnaas J, Mosberg HI, &, Ramamoorthy A, (2002) Membrane composition determines pardaxin's mechanism of lipid bilayer disruption. Biophys J 83, 1004-1013.
6. McHenry AJ, Sciacca MF, Brender JR, &, Ramamoorthy A, (2012) Does cholesterol suppress the antimicrobial peptide induced disruption of lipid raft containing membranes? Biochim Biophys Acta 1818, 3019-3024.
7. Henzler-Wildman KA, Martinez GV, Brown MF, &, Ramamoorthy A, (2004) Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37. Biochemistry 43, 8459-8469.
8. Epand RF, Maloy L, Ramamoorthy A, &, Epand RM, (2010) Amphipathic helical cationic antimicrobial peptides promote rapid formation of crystalline states in the presence of phosphatidylglycerol: lipid clustering in anionic membranes. Biophys J 98, 2564-2573.
9. Epand RF, Maloy WL, Ramamoorthy A, &, Epand RM, (2010) Probing the 'charge cluster mechanism' in amphipathic helical cationic antimicrobial peptides. Biochemistry 49, 4076-4084.
10. Nicolas P, (2009) Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides. FEBS J 276, 6483-6496.
11. Jordan JB, Poppe L, Haniu M, Arvedson T, Syed R, Li V, Kohno H, Kim H, Schnier PD, Harvey TS, et al,. (2009) Hepcidin revisited, disulfide connectivity, dynamics, and structure. J Biol Chem 284, 24155-24167.
12. Krause A, Neitz S, Magert HJ, Shulz A, Forssmann WG, Schulz-Knappe P, &, Adermann K, (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480, 147-150.
13. Hunter HN, Fulton DB, Ganz T, &, Vogel HJ, (2002) The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 277, 37597-37603.
14. Park CH, Valore EV, Waring AJ, &, Ganz T, (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276, 7806-7810.
15. De Domenico I, Ward DM, &, Kaplan J, (2007) Hepcidin regulation: ironing out the details. J Clin Invest 117, 1755-1758.
16. Ganz T, &, Nemeth E, (2012) Hepcidin and iron homeostasis. Biochim Biophys Acta 1823, 1434-1443.
17. Kartikasari AE, Roelofs R, Schaeps RM, Kemma EH, Peters WH, Swinkels DW, &, Tjalsma H, (2008) Secretion of bioactive hepcidin-25 by liver cells correlates with its gene transcription and points towards synergism between iron and inflammation signaling pathways. Biochim Biophys Acta 1784, 2029-2037.
18. Maisetta G, Petruzzelli R, Brancatisano FL, Esin S, Vitali A, Campa M, &, Batoni G, (2010) Antimicrobial activity of human hepcidin 20 and 25 against clinically relevant bacterial strains: effect of copper and acidic pH. Peptides 31, 1995-2002.
19. Tavanti A, Maisetta G, Del Gaudio G, Petruzzelli R, Sanguinetti M, Batoni G, &, Senesi S, (2011) Fungicidal activity of the human peptide hepcidin 20 alone or in combination with other antifungals against Candida glabrata isolates. Peptides 32, 2484-2487.
20. Kacprzyk L, Rydengård V, Mörgelin M, Davoudi M, Pasupuleti M, Malmsten M, &, Schmidtchen A, (2007) Antimicrobial activity of histidine-rich peptides is dependent on acidic conditions. Biochim Biophys Acta 1768, 2667-2680.
21. Schibli DJ, Hunter HN, Aseyev V, Starner TD, Wiencek JM, McCray PB Jr, Tack BF, &, Vogel HJ, (2002) The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J Biol Chem 277, 8279-8289.
22. Bruschi M, Pirri G, Giuliani A, Nicoletto SF, Baster I, Scorciapino MA, Casu M, &, Rinaldi AC, (2010) Synthesis, characterization, antimicrobial activity and LPS-interaction properties of SB041, a novel dendrimeric peptide with antimicrobial properties. Peptides 31, 1459-1467.
23. Steffen H, Rieg S, Wiedemann I, Kalbacher H, Deeg M, Sahl HG, Peschel A, Gotz F, Garbe C, &, Schittek B, (2006) Naturally processed dermicidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob Agents Chemother 50, 2608-2620.
24. Kolusheva S, Shahal T, &, Jelinek R, (2000) Peptide-membrane interactions studied by a new phospholipid/polydiacetylene colorimetric vesicle assay. Biochemistry 39, 15851-15859.
25. Kolusheva S, Boyer L, &, Jelinek R, (2000) A colorimetric assay for rapid screening of antimicrobial peptides. Nat Biotechnol 18, 225-227.
26. Oursel D, Loutelier-Bourhis C, Orange N, Chevalier S, Norris V, &, Lange CM, (2007) Lipid composition of membranes of Escherichia coli by liquid chromatography/tandem mass spectrometry using negative electrospray ionization. Rapid Commun Mass Spectrom 21, 1721-1728.
27. Epand RM, &, Epand RF, (2009) Lipid domains in bacterial membranes and the action of antimicrobial agents. Biochim Biophys Acta 1788, 289-294.
28. Boniotto M, Antcheva N, Zelezetsky I, Tossi A, Palumbo V, Verga Falzacappa MV, Sgubin S, Braida L, Amoroso A, &, Crovella S, (2003) A study of host defence peptide β-defensin 3 in primates. Biochem J 374, 707-714.
29. Skerlavaj B, Benincasa M, Risso A, Zanetti M, &, Gennaro R, (1999) SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes. FEBS Lett 463, 58-62.
30. Matsuzaki K, Sugishita K, Harada M, Fujii N, &, Miyajima K, (1997) Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim Biophys Acta 1327, 119-130.
31. Mangoni ML, Papo N, Barra D, Simmaco M, Bozzi A, Di Giulio A, &, Rinaldi AC, (2004) Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli. Biochem J 380, 859-865.
32. Hancock RE, &, Scott MG, (2000) The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci USA 97, 8856-8861.
33. Hartmann M, Berditsch M, Hawecker J, Ardakani MF, Gerthsen D, &, Ulrich AS, (2010) Damage of the bacterial cell envelope by antimicrobial peptides gramicidin S and PGLa as revealed by transmission and scanning electron microscopy. Antimicrob Agents Chemother 54, 3132-3142.
34. Aktas M, Wessel M, Hacker S, Klüsener S, Gleichenhagen J, &, Narberhaus F, (2010) Phosphatidylcholine biosynthesis and its significance in bacteria interacting with eukaryotic cells. Eur J Cell Biol 12, 888-894.
35. Lieber MR, &, Steck TL, (1982) A description of the holes in human erythrocyte membrane ghosts. J Biol Chem 257, 11651-11659.
36. Ladokhin AS, Selste ME, &, White SH, (1997) Sizing membrane pores in lipid vesicles by leakage of co-encapsulated markers: pore formation by melittin. Biophys J 72, 1762-1766.
37. Yount NY, &, Yeaman MR, (2005) Immunocontinuum: perspectives in antimicrobial peptide mechanisms of action and resistance. Protein Pept Lett 12, 49-67.
38. Scocchi M, Tossi A, &, Gennaro R, (2011) Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action. Cell Mol Life Sci 68, 2317-2330.
39. van Kan EJ, Demel RA, Breukink E, van der Bent A, &, de Kruijff B, (2002) Clavanin permeabilizes target membranes via two distinctly different pH-dependent mechanisms. Biochemistry 41, 7529-7539.
40. Li L, He J, Eckert R, Yarbrough D, Lux R, Anderson M, &, Shi W, (2010) Design and characterization of an acid activated antimicrobial peptide. Chem Biol Drug Des 75, 127-132.
41. Mason AJ, Gasnier C, Kichler A, Prévost G, Aunis D, Metz-Boutigue MH, &, Bechinger B, (2006) Enhanced membrane disruption and antibiotic action against pathogenic bacteria by designed histidine-rich peptides at acidic pH. Antimicrob Agents Chemother 50, 3305-3311.
42. Yoo S, Kim JY, Park SC, Choi do Y, Seo CH, Hahm KS, &, Park Y, (2011) Effect of acidic pH on antibacterial action of peptide isolated from Korean pen shell (Atrina pectinata). J Pept Sci 17, 353-357.
43. Gagliardo B, Faye A, Jaouen M, Deschemin JC, Canonne-Hergaux F, Vaulont S, &, Sari MA, (2008) Production of biologically active forms of recombinant hepcidin, the iron-regulatory hormone. FEBS J 275, 3793-3803.
44. Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, &, Lafuse WP, (2007) Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J Leukoc Biol 82, 934-945.
45. Sow FB, Nandakumar S, Velu V, Kellar KL, Schlesinger LS, Amara RR, Lafuse WP, Shinnick TM, &, Sable SB, (2011) Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin. Tuberculosis 91, 314-321.
46. Schwarz P, Kübler JA, Strnad P, Müller K, Barth TF, Gerloff A, Feick P, Peyssonnaux C, Vaulont S, Adler G, et al,. (2012) Hepcidin is localised in gastric parietal cells, regulates acid secretion and is induced by Helicobacter pylori infection. Gut 61, 193-201.
47. Altamura S, Kiss J, Blattmann C, Gilles W, &, Muckenthaler MU, (2009) SELDI-TOF MS detection of urinary hepcidin. Biochimie 91, 1335-1338.
48. Ganz T, Obina G, Girelli D, Nemeth E, &, Westerman M, (2008) Immunoassay for human serum hepcidin. Blood 112, 4292-4296.
49. 1H NMR spectroscopy. J Magn Reson B 104, 1-10.
50. Smallcombe SH, Patt SL, &, Keifer PA, (1995) WET solvent suppression and its applications to LC NMR and high-resolution NMR spectroscopy. J Magn Reson A 117, 295-303.
51. Arancia G, Stringaro A, Crateri P, Torantucci A, Ramoni C, Urbani F, Ausiello CM, &, Cassone A, (1998) Interaction between human interleukin-2-activated natural killer cells and heat-killed germ tube forms of Candida albicans. Cell Immunol 186, 28-38.
52. Rinaldi AC, Di Giulio A, Liberi M, Gualtieri G, Oratore A, Bozzi A, Schininà ME, &, Simmaco M, (2001) Effects of temporins on molecular dynamics and membrane permeabilization in lipid vesicles. J Pept Res 58, 213-220.
53. Connor J, Yatvin MB, &, Huang L, (1984) pH-sensitive liposomes: acid-induced liposome fusion. Proc Natl Acad Sci USA 81, 1715-1718.
54. Ellens H, Bentz J, &, Szoka FC, (1984) pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact. Biochemistry 23, 1532-1538.
55. Matsuzaki K, Sugishita K, &, Miyajima K, (1999) Interactions of an antimicrobial peptide, magainin 2, with lipopolysaccharide-containing liposomes as a model for outer membranes of Gram-negative bacteria. FEBS Lett 449, 221-224.